Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2009 Financial Results
February 20th, 2009
Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced financial results for the three months ended December 31, 2008. The Company reported a net loss of $459,000, or $0.01 per basic share, compared to a loss of $641,000, or $0.02 per basic share, for the three months ended December 31, 2007, a decrease of 28%. “Results for the quarter continue to demonstrate our success in reducing overhead and successfully partnering with universities and the government to further the development of AEOL 10150,” stated John L. McManus, President and Chief Executive Officer. “While making wise use of our cash is important, it is also critical that we move forward the development of our...
Source: Health Business Week (2009-02-20)
|
